Crossmark

A gold(<scp>i</scp>) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugs

Crossref DOI link: https://doi.org/10.1039/C8MT00306H

Published Online: 2018-11-26

Published Print: 2019-03-20

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Schmidt, Claudia https://orcid.org/0000-0001-8532-2604
Albrecht, Lucia

Balasupramaniam, Shantheya

Misgeld, Rainer

Karge, Bianka

Brönstrup, Mark https://orcid.org/0000-0002-8971-7045
Prokop, Aram

Baumann, Knut https://orcid.org/0000-0001-9459-0045
Reichl, Stephan

Ott, Ingo https://orcid.org/0000-0002-8087-4618
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (OT338/12-1, BR 3572/4-1)

Deutsche Forschungsgemeinschaft (OT338/12-1, BR 3572/4-1)
License Information

Version of Record valid from 2018-11-26

Accepted Manuscript valid from 2019-11-26
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Claudia Schmidt (ORCID)

: Mark Brönstrup (ORCID)

: Knut Baumann (ORCID)

: Ingo Ott (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 25 October 2018; Accepted 26 November 2018; Accepted Manuscript published 26 November 2018; Advance Article published 5 December 2018; Version of Record published 20 March 2019

Document is current

Any future updates will be listed below